ViroStatics Competitors and Similar CompaniesClear all
ViroStatics's competitors and similar companies include Halozyme Therapeutics and Ablynx.
 Halozyme Therapeutics Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment. |  Ablynx Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. | ||
Founding Date | Founding Date 2005 | Founding Date 1998 | Founding Date 2001 |
Type | Type Private | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Sassari, IT HQ Tramariglio, IT | Locations San Diego, US HQ | Locations Gent, BE HQ |
Employees | Employees 8 | Employees 373157% increase | Employees 1252% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $1.4b (FY, 2025) | Revenue (est.) €85.2m (FY, 2016) |
Net income | Net income N/A | Net income $316.9m (FY, 2025) | Net income (€1.1m) (FY, 2016) |
Operating ⚠ | |||
Patents (US) | Patents (US) N/A | Patents (US) 43 (FY, 2020) | Patents (US) 50 (Q2, 2017) |
Funding | |||
Total funding raised | Total funding raised $ 53k | Total funding raised $ 171.9m | Total funding raised $ 498.8m |
For sources of this data, please see the company profile
View Company Profiles
Halozyme Therapeutics
HQ
San Diego, US
Employees
373
Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.
View companyAblynx
HQ
Gent, BE
Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.
View company